Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17334222 | 0.84 | GAA (0.40) | GAA | |
| SCHEMBL23113093 | 0.82 | ALDH1A1 (0.35) | — | |
| SCHEMBL17574069 | 0.75 | GAA (0.48) | GAA | |
| SCHEMBL13548866 | 0.73 | GAA (0.46) | GAA | |
| SCHEMBL9627444 | 0.73 | GAA (0.46) | GAA | |
| SCHEMBL10456471 | 0.72 | GAA (0.50) | GAA | |
| SCHEMBL9138775 | 0.72 | GAA (0.56) | GAA | |
| SCHEMBL29090047 | 0.70 | — | — | |
| SCHEMBL66105 | 0.70 | — | — | |
| SCHEMBL4110980 | 0.70 | ALDH1A1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10246474-B2 | Preparation of a hydroxyalkyl phosphonic acid | ROHM AND HAAS COMPANY (US) | 2019-04-02 | — | — | US | claimed |
| EP-2957564-B1 | PREPARATION OF A HYDROXYALKYL PHOSPHONIC ACID | ROHM & HAAS (US) | 2018-09-12 | — | — | EP | claimed |
| EP-2957564-A1 | PREPARATION OF A HYDROXYALKYL PHOSPHONIC ACID | Rohm and Haas Company (US) | 2015-12-23 | — | — | EP | claimed |
| US-20150361117-A1 | PREPARATION OF A HYDROXYALKYL PHOSPHONIC ACID | ROHM AND HAAS COMPANY | 2015-12-17 | — | — | US | claimed |
| US-10246474-B2 | Preparation of a hydroxyalkyl phosphonic acid | ROHM AND HAAS COMPANY (US) | 2019-04-02 | — | — | US | disclosed |
| EP-2957564-B1 | PREPARATION OF A HYDROXYALKYL PHOSPHONIC ACID | ROHM & HAAS (US) | 2018-09-12 | — | — | EP | disclosed |
| EP-2957564-A1 | PREPARATION OF A HYDROXYALKYL PHOSPHONIC ACID | Rohm and Haas Company (US) | 2015-12-23 | — | — | EP | disclosed |
| US-20150361117-A1 | PREPARATION OF A HYDROXYALKYL PHOSPHONIC ACID | ROHM AND HAAS COMPANY | 2015-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10246474-B2 | Preparation of a hydroxyalkyl phosphonic acid | PHOSPHO1, PIK3CA, PHPT1 | GAA 825/4885 |
| US-20150361117-A1 | PREPARATION OF A HYDROXYALKYL PHOSPHONIC ACID | PHOSPHO1, PIK3CA, PHPT1 | GAA 825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.